Clinical Trial Update: Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on pharmacokinetics and safety of MM36 topical ointment in children with atopic dermatitis; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MM36 topical ointment (MM36 topical ointment)

Snippet

Sponsor: Medimetriks Pharmaceuticals, Inc | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-11-19